Salus Discovery LLC
Monona, WI
- UEI
- YJ6CYLKZ4JL9
- CAGE
- 75YV3
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Partnership or Limited Liability Partnership
- SAM.gov registration date
- Physical address
- 4647 Tonyawatha Trail, Monona, WI 53716, USA
- Website
- salusd.com
- Founded
- 2013
- Employees
- 1-10
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Biotechnology
- SIC code
- 87 Engineering & Management Services
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| The microvoa: enhancing the viral outgrowth assay (VOA) with microtechnology | National Institute of Allergy and Infectious Diseases (NIH) | $298,743 |
Grant awards
Latest 5 listed here. See the rest on GovTribe.
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Prompt Diagnostics, Inc. | Baltimore, MD | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
| Big Eye Diagnostics Inc. | San Diego, CA | 325413 In-Vitro Diagnostic Substance Manufacturing |
| Hemex Health Inc. | Portland, OR | 334510 Electromedical and Electrotherapeutic Apparatus Manufacturing |
| Lo Biosciences, Inc. | North Bethesda, MD | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
| Gate Scientific, Inc. | Milpitas, CA | 334516 Analytical Laboratory Instrument Manufacturing |
About the company
Salus Discovery LLC is a for-profit limited liability company specializing in the development of innovative molecular diagnostic technologies for infectious diseases. Registered in SAM.gov since May 2014, the company focuses on creating point-of-care (POC) nucleic acid testing solutions to address unmet needs in affordable and accessible diagnostics, particularly for underserved communities. Salus Discovery's primary contributions to the federal government through grant awards involve the research and development of cutting-edge diagnostic platforms for various infectious diseases, including tuberculosis (TB), sexually transmitted infections (STIs), and schistosomiasis. These technologies aim to improve the accuracy, accessibility, and affordability of diagnostic testing in resource-limited settings and at the point of care.
Through federal grant awards, Salus Discovery has undertaken several significant projects. The company has developed the 3STEP platform, a swab-seal-read assay for TB and rifampicin resistance detection, as well as for STI screening. They are also working on enhancing schistosomiasis detection through urine-based analyte pre-concentration technology, collaborating with experts from Leiden University Medical Center. Additionally, Salus Discovery has received funding to improve pediatric TB diagnosis using their proprietary FLOW technology. These projects are primarily funded by the National Institutes of Health, specifically through the National Institute of Allergy and Infectious Diseases (NIAID) and the National Institute of Child Health and Human Development (NICHD), under programs such as the Allergy and Infectious Diseases Research program (CFDA 93.855). As a sub-grantee, Salus Discovery participates in the Atlanta Center for Microsystems Engineered Point-of-Care Technologies (ACME POCT) program, contributing to the advancement of point-of-care diagnostic technologies in partnership with Emory University. These diverse projects demonstrate Salus Discovery's commitment to addressing critical healthcare needs through innovative diagnostic solutions for global health challenges.
Quick answers
Is Salus Discovery LLC registered in SAM.gov?
Yes. Salus Discovery LLC's SAM.gov registration is active through June 10, 2027.
What is Salus Discovery LLC's most recent federal award?
Salus Discovery LLC's most recent federal grant award is Flow direct: next generation urine LFA for TB diagnosis in point-of-care settings (R44AI184104), from National Institute of Allergy and Infectious Diseases (NIH), on July 10, 2024.
On GovTribe
See Salus Discovery LLC's full federal record
- Federal contract awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors